Janus Henderson Group’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $246M | Sell |
2,835,816
-278,342
| -9% | -$26.7M | 0.12% | 171 |
|
|
2025
Q4 | $299M | Sell |
3,114,158
-437,994
| -12% | -$42.5M | 0.13% | 151 |
|
|
2025
Q3 | $338M | Sell |
3,552,152
-224,493
| -6% | -$20.6M | 0.15% | 127 |
|
|
2025
Q2 | $329M | Sell |
3,776,645
-844,135
| -18% | -$71.6M | 0.16% | 134 |
|
|
2025
Q1 | $405M | Buy |
4,620,780
+743,248
| +19% | +$66.5M | 0.22% | 106 |
|
|
2024
Q4 | $310M | Buy |
3,877,532
+26,618
| +0.7% | +$2.3M | 0.16% | 145 |
|
|
2024
Q3 | $347M | Buy |
3,850,914
+1,420,263
| +58% | +$119M | 0.18% | 132 |
|
|
2024
Q2 | $191M | Sell |
2,430,651
-1,056,843
| -30% | -$86.6M | 0.1% | 176 |
|
|
2024
Q1 | $304M | Sell |
3,487,494
-14,162
| -0.4% | -$1.21M | 0.17% | 140 |
|
|
2023
Q4 | $289M | Sell |
3,501,656
-231,038
| -6% | -$17.6M | 0.17% | 138 |
|
|
2023
Q3 | $292M | Buy |
3,732,694
+792,937
| +27% | +$66.4M | 0.19% | 131 |
|
|
2023
Q2 | $259M | Sell |
2,939,757
-33,828
| -1% | -$2.91M | 0.16% | 146 |
|
|
2023
Q1 | $240M | Sell |
2,973,585
-1,080,954
| -27% | -$88.1M | 0.16% | 147 |
|
|
2022
Q4 | $315M | Sell |
4,054,539
-3,516,483
| -46% | -$285M | 0.23% | 116 |
|
|
2022
Q3 | $611M | Buy |
7,571,022
+3,649,943
| +93% | +$328M | 0.23% | 114 |
|
|
2022
Q2 | $352M | Sell |
3,921,079
-764,870
| -16% | -$77.5M | 0.24% | 112 |
|
|
2022
Q1 | $520M | Sell |
4,685,949
-564,170
| -11% | -$59.6M | 0.25% | 92 |
|
|
2021
Q4 | $543M | Sell |
5,250,119
-1,611,232
| -23% | -$187M | 0.23% | 107 |
|
|
2021
Q3 | $860M | Sell |
6,861,351
-320,268
| -4% | -$41.5M | 0.38% | 58 |
|
|
2021
Q2 | $891M | Sell |
7,181,619
-228,131
| -3% | -$28.6M | 0.38% | 57 |
|
|
2021
Q1 | $875M | Sell |
7,409,750
-290,063
| -4% | -$34M | 0.4% | 54 |
|
|
2020
Q4 | $902M | Buy |
7,699,813
+477,533
| +7% | +$52.6M | 0.42% | 53 |
|
|
2020
Q3 | $750M | Buy |
7,222,280
+2,378,463
| +49% | +$239M | 0.39% | 50 |
|
|
2020
Q2 | $444M | Buy |
4,843,817
+398,438
| +9% | +$38.2M | 0.25% | 93 |
|
|
2020
Q1 | $401M | Sell |
4,445,379
-182,982
| -4% | -$19.5M | 0.28% | 83 |
|
|
2019
Q4 | $525M | Buy |
4,628,361
+56,486
| +1% | +$6.2M | 0.27% | 92 |
|
|
2019
Q3 | $497M | Buy |
+4,571,875
| New | +$477M | 0.27% | 88 |
|
|
2018
Q1 | – | Sell |
-7,327,699
| Closed | -$592M | – | 1376 |
|
|
2017
Q4 | $592M | Sell |
7,327,699
-129,663
| -2% | -$10.4M | 0.36% | 62 |
|
|
2017
Q3 | $580M | Buy |
+7,457,362
| New | +$619M | 0.37% | 58 |
|
|
2017
Q1 | – | Sell |
-183,577
| Closed | -$13.1M | – | 851 |
|
|
2016
Q4 | $13.1M | Buy |
183,577
+16,281
| +10% | +$1.28M | 0.1% | 245 |
|
|
2016
Q3 | $14.5M | Sell |
167,296
-4,597
| -3% | -$401K | 0.11% | 233 |
|
|
2016
Q2 | $14.9M | Buy |
+171,893
| New | +$13.9M | 0.12% | 206 |
|
|
2015
Q1 | – | Sell |
-139,299
| Closed | -$10.1M | – | 851 |
|
|
2014
Q4 | $10.1M | Hold |
139,299
| – | – | 0.07% | 285 |
|
|
2014
Q3 | $8.63M | Sell |
139,299
-8,463
| -6% | -$538K | 0.08% | 220 |
|
|
2014
Q2 | $9.42M | Sell |
147,762
-4,880
| -3% | -$296K | 0.09% | 216 |
|
|
2014
Q1 | $9.39M | Buy |
152,642
+28,616
| +23% | +$1.67M | 0.09% | 213 |
|
|
2013
Q4 | $7.12M | Hold |
124,026
| – | – | 0.07% | 242 |
|
|
2013
Q3 | $6.61M | Buy |
124,026
+4,528
| +4% | +$244K | 0.07% | 236 |
|
|
2013
Q2 | $6.22M | Buy |
+119,498
| New | +$5.91M | 0.07% | 238 |
|
Other funds holding MDT
VCM
VPM
Janus Henderson Group's MDT Position: Q1 2026 in Review
Janus Henderson Group reduced its Medtronic (MDT) stake by 8.9% in Q1 2026, selling an estimated $26.7M and leaving 2,835,816 shares worth $246M. The position accounts for 0.12% of the portfolio, ranked #171.
Janus Henderson Group first reported a position in MDT in Q2 2013 and has held it in 39 quarters since. The position peaked at $902M in Q4 2020. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Janus Henderson Group held 2,835,816 shares of Medtronic worth $246M as of Q1 2026.
- Janus Henderson Group sold 278,342 Medtronic shares in Q1 2026, an estimated $26.7M.
- Medtronic made up 0.12% of Janus Henderson Group's portfolio in Q1 2026, its #171 holding.
- Janus Henderson Group first reported a position in Medtronic in Q2 2013 and has held it in 39 quarters since.
- Janus Henderson Group's Medtronic position peaked at $902M in Q4 2020.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.